{"title": "Responding to Vaccine Safety Signals during Pandemic Influenza: A Modeling Study", "author": "Maro; Judith C; Fryback; Dennis G; Lieu; Tracy A; Lee; Grace M; Martin; David B", "url": null, "hostname": null, "description": "Background: Managing emerging vaccine safety signals during an influenza pandemic is challenging. Federal regulators must balance vaccine risks against benefits while maintaining public confidence in the public health system. Methods: We developed a multi-criteria decision analysis model to explore regulatory decision-making in the context of emerging vaccine safety signals during a pandemic. We simulated vaccine safety surveillance system capabilities and used an age-structured compartmental model to develop potential pandemic scenarios. We used an expert-derived multi-attribute utility function to evaluate potential regulatory responses by combining four outcome measures into a single measure of interest: 1) expected vaccination benefit from averted influenza; 2) expected vaccination risk from vaccine-associated febrile seizures; 3) expected vaccination risk from vaccine-associated Guillain-Barre Syndrome; and 4) expected change in vaccine-seeking behavior in future influenza seasons. Results: Over multiple scenarios, risk communication, with or without suspension of vaccination of high-risk persons, were the consistently preferred regulatory responses over no action or general suspension when safety signals were detected during a pandemic influenza. On average, the expert panel valued near-term vaccine-related outcomes relative to long-term projected outcomes by 31. However, when decision-makers had minimal ability to influence near-term outcomes, the response was selected primarily by projected impacts on future vaccine-seeking behavior. Conclusions: The selected regulatory response depends on how quickly a vaccine safety signal is identified relative to the peak of the pandemic and the initiation of vaccination. Our analysis suggested two areas for future investment: efforts to improve the size and timeliness of the surveillance system and behavioral research to understand changes in vaccine-seeking behavior.", "sitename": "Public Library of Science", "date": "2015-01-05", "cleaned_text": "Responding to Vaccine Safety Signals during Pandemic Influenza: A Modeling Study Author Fryback, Dennis G. Lieu, Tracy A. Martin, David B. Published Version [https://doi.org/10.1371/journal.pone.0115553](https://doi.org/10.1371/journal.pone.0115553) Metadata [Show full item record](/handle/1/13581228?show=full) CitationMaro, Judith C., Dennis G. Fryback, Tracy A. Lieu, Grace M. Lee, and David B. Martin. 2014. \"Responding to Vaccine Safety Signals during Pandemic Influenza: A PLoS ONE 9 (12): e115553. doi:10.1371/journal.pone.0115553. http://dx.doi.org/10.1371/journal.pone.0115553. AbstractBackground: Managing emerging vaccine safety signals during an influenza pandemic is challenging. Federal regulators must balance vaccine risks against benefits while maintaining public confidence in the public health system. Methods: We developed a multi-criteria decision analysis model to explore regulatory decision-making in the context of emerging vaccine safety signals during a pandemic. We simulated vaccine safety surveillance system capabilities and used an age-structured compartmental model to develop potential pandemic scenarios. We used an expert-derived multi-attribute utility function to evaluate potential regulatory responses by combining four outcome measures into a single measure of interest: 1) expected vaccination benefit from averted influenza; 2) expected vaccination risk from vaccine-associated febrile seizures; 3) expected vaccination risk from vaccine-associated Guillain-Barre Syndrome; and 4) expected change in vaccine-seeking behavior in future influenza seasons. Results: Over multiple scenarios, risk communication, with or without suspension of vaccination of high-risk persons, were the consistently preferred regulatory responses over no action or general suspension when safety signals were detected during a pandemic influenza. On average, the expert panel valued near-term vaccine-related outcomes relative to long-term projected outcomes by 31. However, when decision-makers had minimal ability to influence near-term outcomes, the response was selected primarily by projected impacts on future vaccine-seeking behavior. Conclusions: The selected regulatory response depends on how quickly a vaccine safety signal is identified relative to the peak of the pandemic and the initiation of vaccination. Our analysis suggested two areas for future investment: efforts to improve the size and timeliness of the surveillance system and behavioral research to understand changes in vaccine-seeking behavior. Other Sources [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4275236/pdf/](http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4275236/pdf/) Terms of UseThis article is made available under the terms and conditions applicable to Other Posted Material, as set forth at [http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA](http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA) Citable link to this page [http://nrs.harvard.edu/urn-3:HUL.InstRepos:13581228](http://nrs.harvard.edu/urn-3:HUL.InstRepos:13581228) Collections - [HMS Scholarly Articles](/handle/1/4454686)[17841] [Contact administrator regarding this item (to "}